Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
9-NOV-1999 - 20-DEC-1999
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2000
Report date:
2000

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
(1993)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
The study was conducted in 2000, when the GPMT was an international accepted and recommended method to assess sensitizing potential.

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
434-070-2
EC Name:
-
Cas Number:
268567-32-4
Molecular formula:
C12 H25 O4 P S2
IUPAC Name:
3-{[bis(2-methylpropoxy)(sulfanylidene)-λ⁵-phosphanyl]sulfanyl}-2-methylpropanoic acid
Test material form:
liquid: viscous
Specific details on test material used for the study:
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Stability under test conditions: Stable in PEG 400 and in a 1:1 (v/v) mixture of FCA/physiological saline for at least 2 h

In vivo test system

Test animals

Species:
guinea pig
Strain:
other: Ibm: GOHI; SPF-quality
Sex:
male
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: RCC Ltd. Biotechnology & Animal Breeding Division, CH-4414 Füllinsdorf / Switzerland.
- Age at study initiation: 5 - 7 weeks.
- Weight at study initiation: 337 - 371 g.
- Housing: individually in Makrolon type-4cages.
- Diet: pelleted standard Nafag Ecosan 845 25W4, guinea pig breeding/maintenance diet (containing Vitamin C), ad libitum.
- Water: tap water, ad libitum.
- Acclimation period: 1 week.

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3
- Humidity (%): 40 - 70
- Air changes (per hr): 10 - 15
- Photoperiod (hrs dark / hrs light): 12 / 12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
polyethylene glycol
Concentration / amount:
50 %
Day(s)/duration:
day 0
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
0.3 mL; 100 %
Day(s)/duration:
day 8 / 48 h
Challenge
No.:
#1
Route:
epicutaneous, occlusive
Vehicle:
polyethylene glycol
Concentration / amount:
50 %
Day(s)/duration:
day 21 / 24 h
No. of animals per dose:
Pretest: 3 animals.
Main test: 10 animals in treatment group, 5 animals in control group.
Details on study design:
RANGE FINDING TESTS:
Pretest:
Intradermal Injection:
Four intradermal injections (0.1 mL/site) of a 1:1 mixture of FCA/physiological saline were made in the shaved neck of one guinea pig. One week later intradermal injection (0.1 mL/site) was made into the clipped flank of the same guinea pig at concentrations of 100 %, 75 % and 50 % of the test article in PEG 400. Dermal reactions were assessed 24 h later. Based on the results a concentration of 50 % was selected for intradermal induction in the main study.
Epidermal Application:
Four intradermal injections (0.1 ml/site) of a 1:1 mixture of FCA/physiological saline were made in the shaved neck of two guinea pigs. One week later, 4 patches were saturated with the test article at concentrations of 100 %, 75 %, 50 % and 25 % in PEG 400, respectively. The patches were applied to the clipped and shaved flanks of each of the two animals under occlusive conditions. The exposure period was 24 h. After removal of the patches the skin was examined for signs of irritation.
According to results of the pretest for intradermal injection (induction) in the main study a concentration of 50 % of test article in vehicle was selected. Undiluted (100 %) test article was selected for epidermal induction, and 50 % in vehicle for epidermal challenge.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2;
Intradermal: three pairs of intradermal injections (1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline, the test article, at 50 % in PEG 400 and the test article at 50 % in a 1:1 (v/v) mixture of Freund's Complete Adjuvant and physiological saline; 0.1 mL/site)
Epidermal: undiluted test article one week after intradermal injections.
- Exposure period: epidermal application was performed for 48 h.
- Test groups: 10 males.
- Control group: 5 males.
- Site: dorsal skin from the scapular region.

B. CHALLENGE EXPOSURE (TWO WEEKS AFTER INDUCTION)
- No. of exposures: 1.
- Day(s) of challenge: 1.
- Exposure period: 24 h.
- Test groups: 10 males.
- Control group: 5 males.
- Site: flank.
- Concentrations: 50 % test article in vehicle.
- Evaluation (hr after challenge): approximately 25 and 48 hours after challenge.
Challenge controls:
PEG 400
Positive control substance(s):
yes
Remarks:
2-Mercaptobenzothiazole (independently performed, report attached)

Results and discussion

Positive control results:
Validation of sensitivity of the Maximization-Test was performed from 1998-12-01 to 1999-01-08 (RCC Project 903407). In accordance to OECD 406, 2-Mercaptobenzothiazole was selected as a positive control. The intradermal induction of sensitization was performed with a 5 % dilution of the test article in mineral oil and in an emulsion of FCA/physiological saline. The epidermal induction of sensitization was conducted under occlusion with the test article at 50 % in mineral oil. Two weeks after the epidermal induction application the challenge was completed by epidermal application of the test article at 10 % in mineral oil under occlusive dressing. The animals of the control group were induced with mineral oil and FCA/physiological saline and challenged similarly to those of the test group. Cutaneous reactions, i.e. erythema and eschar, as well as edema formation were evaluated at 24 and 48 hours after removal of the dressing.
90 % (at the 24-hour reading) and 100 % (at the 48-hour reading) of the animals of the test group were observed with very slight to moderate/severe erythematous reactions after treatment with a non-irritant test article concentration of 10 % in mineral oil. No skin reactions were observed in the control group.

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0 %
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no skin irritations were observed
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
50 %
No. with + reactions:
7
Total no. in group:
10
Clinical observations:
positive reactions consisted of discrete/patchy to intense erythema and swelling of the skin
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
0 %
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
no skin irritations were observed
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
50 %
No. with + reactions:
7
Total no. in group:
10
Clinical observations:
positive reactions consisted of discrete/patchy to moderate/confluent erythema

Any other information on results incl. tables

Details on skin reactions after the challenge procedure

Reading time point

24 h

48 h

 

positive

total

% positive of total

positive

total

% positive total

Control group (induced without test article)

challenged with the test item 50 % in PEG 400

0

5

0

0

5

0

challenged with PEG 400

0

5

0

0

5

0

Test group (induced with test article)

challenged with the test item 50 % in PEG 400

7

10

70

7

10

70

challenged with PEG 400

0

10

0

0

10

0

Remark:

No toxic symptoms and no mortality were observed in the animals.

Applicant's summary and conclusion

Interpretation of results:
Category 1B (indication of skin sensitising potential) based on GHS criteria